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The auxiliary 3-subunit is an important functional regu-
lator of the cardiac sodium channel Nav1.5, and some 3
mutations predispose individuals to cardiac arrhythmias.
The 3-subunit uses its transmembrane -helix and extracel-
lular domain to bind to Nav1.5. Here, we investigated the role
of an unusually located and highly conserved glutamic acid
(Glu-176) within the 3 transmembrane region and its poten-
tial for functionally synergizing with the 3 extracellular
domain (ECD). We substituted Glu-176 with lysine (E176K)
in the WT 3-subunit and in a 3-subunit lacking the ECD.
Patch-clamp experiments indicated that the E176K substitu-
tion does not affect the previously observed 3-dependent
depolarizing shift of V1⁄2 of steady-state inactivation but does
attenuate the accelerated recovery from inactivation con-
ferred by the WT 3-subunit. Removal of the 3-ECD abro-
gated both the depolarizing shift of steady-state inactivation
and the accelerated recovery, irrespective of the presence or
absence of the Glu-176 residue. We found that steady-state
inactivation and recovery from inactivation involve move-
ments of the S4 helices within the DIII and DIV voltage sen-
sors in response to membrane potential changes. Voltage-
clamp fluorometry revealed that the E176K substitution
alters DIII voltage sensor dynamics without affecting DIV. In
contrast, removal of the ECD significantly altered the dynam-
ics of both DIII and DIV. These results imply distinct roles for
the 3-Glu-176 residue and the 3-ECD in regulating the
conformational changes of the voltage sensors that determine
channel inactivation and recovery from inactivation.
The voltage-gated sodium (Nav) channel is an intrinsic
plasma membrane protein complex that initiates the action
potential in electrically excitable cells. The Nav channel is com-
posed of a 250-kDa -subunit, which consists of four homo-
logous domains (DI–DIV) containing the voltage-sensing
domains (VSDs)5 and the ion-selective pore, in association with
one or more auxiliary -subunits that modify the gating behav-
ior of the channel (1). In cardiac tissue, Nav1.5 is the predomi-
nant isoform. Mutations in Nav1.5 predispose to potentially
fatal cardiac arrhythmias, such as the long QT and Brugada
(BrS) syndromes (2). There is increasing evidence that the aux-
iliary 3-subunit is a major physiological regulator of the Nav1.5
-subunit. For example, mice lacking 3 expression exhibit BrS-
like cardiopathologies (3, 4). Furthermore, several BrS patients
have been identified with mutations in the 3-subunit (5–8).
The 3-subunit contains an N-terminal extracellular domain
(ECD), consisting of an Ig domain connected to a short, flexible,
and probably disordered neck. This region is connected to a
single transmembrane -helix and a predominantly disordered
intracellular C-terminal region (9, 10) (see Fig. 1). Recent struc-
tural evidence suggests that the DIII and DIV VSDs are impli-
cated in the control of Nav channel inactivation (11, 12). Volt-
age-clamp fluorometry (VCF) experiments strongly imply that
in Nav1.5, the 3-subunit influences the gating behavior of
both these VSDs (13, 14). Consistent with this evidence, the
3-subunit accelerates Nav1.5 recovery from the inactivated
state and produces a shift in the voltage, V1⁄2, of steady-state inac-
tivation (13, 15). Although reports vary with respect to the direc-
tion of the voltage shifts, depending on the cell expression system
used, they remain consistent with the 3-subunit altering the elec-
trical field seen by one or more of the channel VSDs (16).
Mutagenesis and deletion experiments indicate that the
3-dependent shift in the V1⁄2 of inactivation requires the pres-
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ence of the ECD (15). However, the role of the 3 transmem-
brane -helix has been less well-studied. We have previously
noted the presence of a highly conserved glutamic acid residue
within the transmembrane region at position 176 (16). The
location is intriguing because glutamic acids are rarely located
in such hydrophobic regions (17). Here we mutate the Glu-176
residue to lysine in both the WT 3-subunit and the 3-subunit
lacking the ECD. We examine the effects of these mutations on
gating behavior and voltage-dependent movements of Nav1.5
DIII and DIV VSDs, using whole-cell patch-clamp electrophys-
iology and VCF. Our results suggest that the 3-subunit trans-
membrane -helix lies close to the DIII VSD, where the Glu-
176 residue plays an important role in facilitating recovery from
inactivation. We further show that the 3-subunit extracellular
region extends its influence both to the DIII and DIV VSDs.
These data provide new structural and functional insights into
how the 3-subunit can modulate both steady-state inactiva-
tion and recovery from inactivation.
Results
Structural insights into the Glu-176 residue and its location
within the transmembrane domain
The amino acid residues referred to in the text are numbered
from the start codon of the cDNA. Thus, the endoplasmic retic-
ulum targeting signal is included in the numbering convention.
Secondary structure predictions identified the likely position
and extent of the transmembrane region as a conserved, hydro-
phobic, -helical region extending from residues 156 to 180.
The transmembrane region of single-pass, type 1 membrane
proteins such as the 3-subunit are often enriched for residues
such as tyrosine and cysteine on the membrane side of the cyto-
plasmic interface, followed on the cytoplasmic side by a cluster
of basic residues (18). All these features are present in the 3
transmembrane region at positions 179 –183 (Fig. 1A). Hence,
the 3 transmembrane -helix is likely to emerge into the cyto-
sol at or close to residues Arg-182 and Lys-183. If so, the Glu-
176 residue will be located almost two -helical turns, or 9 –10
Å, inside the membrane. Interestingly, the Glu-176 residue—
which is fully conserved between all known 3 sequences—lies
on a face of the -helix that is also fully conserved (Fig. 1, A and
B). This suggests the presence of an extended binding site along
the transmembrane -helix, in which the Glu-176 residue is
likely to play an important role.
To investigate the function(s) of the Glu-176 residue, we
used site-directed mutagenesis to replace it with lysine in the
full-length 3 sequence. The lysine side chain has similar
dimensions to the glutamic acid side chain but in aqueous
media carries a positive charge. In a hydrophobic environment,
the pKa of a lysine side chain is between 6 and 6.5 (19, 20).
Hence, even if buried within the membrane, a significant
minority of the lysine should remain positively charged and
thus likely to be electrostatically distinct from the WT glutamic
acid. To investigate the potential for functional synergy
between the Glu-176 residue and the extracellular domain, we
also introduced the E176K mutant into a 3 deletion mutant
lacking the extracellular domain (15). All 3 constructs con-
tained a C-terminal EGFP tag to aid the identification of trans-
fected cells. A diagrammatic summary of the mutational con-
structs used in this work and their naming convention is shown
in Fig. 1C.
The Glu-176 residue is not required for 3-subunit
self-oligomerization
The isolated 3-subunit Ig domain can form trimers in solu-
tion and the full-length 3-subunit forms trimers in the plasma
membrane when expressed in HEK293 cells in the absence of
the Nav channel -subunit (21). We have previously suggested
that the 3-subunit trimer could be stabilized by hydrogen
bonding between the membrane-embedded and protonated
Glu-176 side chains on adjacent transmembrane domains (16).
To test this hypothesis, cross-linking experiments with the
membrane-impermeant bis-sulfosuccinimidyl suberate (BS3)
were carried out on HEK293F cells singly transfected with the
full-length WT 3-subunit and the different 3-subunit muta-
tions (Fig. 2A).
In the absence of the cross-linker BS3, WT-3-EGFP and
E176K-EGFP migrated as monomers on SDS-PAGE (Fig. 2A).
The presence of closely spaced bands is due to multiple glyco-
sylation states (22). Similarly, under these conditions the
3-ECD-EGFP and the 3-ECD-E176K-EGFP proteins
were observed as monomers at 35–38 kDa, In the presence of
BS3, extra bands were observed for the WT-3-EGFP and
E176K-EGFP 3-subunits at 130 –140 and 180 –200 kDa,
indicating the formation of dimers and trimers. There was no
obvious reduction in the extent of cross-linking between WT
and E176K mutant, suggesting that the mutation does not pre-
vent the ability to form dimers and trimers. However, oligomer-
ization induced by cross-linking was lost with the removal of
the ECD, whether or not the resulting ECD construct con-
tained the E176K mutation in its transmembrane region.
Hence, oligomerization depends more on the presence of an
intact ECD than on the transmembrane region. We found no
evidence that the homophilic interactions between individual
3-subunits specifically required the presence of a glutamic
acid at position 176.
Binding of the 3-subunit to the Nav1.5 -subunit persists
with the E176K mutation
Binding of the different 3-subunit variants to the Nav1.5
-subunit was examined by co-immunoprecipitation experi-
ments. Here, a Nav1.5 -subunit with a C-terminal HA tag (21)
was co-transfected with the WT or mutant 3-subunits. This
resulted in the co-immunoprecipitation of all co-expressed
3-subunits, including the 3-ECD-E176K-EGFP mutant that
both lacked the extracellular Ig domain and contained the E176K
change (Fig. 2B). This suggests that neither the extracellular Ig
domain nor the Glu-176 residue alone are essential for the binding
of the 3-subunit to the Nav1.5 -subunit. Interestingly, it was
noticeable that the intensity of the immunoprecipitated 3-E176K
EGFP mutant in the bound fraction was somewhat weaker com-
pared with WT-3 EGFP, whereas the immunoprecipitated
3-ECD (with or without the E176K mutant) was noticeably
more intense. Hence, the Glu-176 residue and the ECD may influ-
ence the overall stability of the Nav1.5–3 complex with Nav1.5 in
different ways (see “Discussion”).
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Loss of the ECD, but not of the Glu-176 residue, abolishes the
effect of the 3-subunit on the voltage sensitivity of Nav1.5
inactivation gating
Stable Nav1.5-HEK293F cells were co-transfected with an
empty EGFP vector (Nav1.5 with EGFP) or EGFP-tagged WT
or mutant 3-subunits (i.e. Nav1.5 with WT-3-EGFP; Nav1.5
with 3-E176K-EGFP; Nav1.5 with 3-ECD-EGFP; and
Nav1.5 with 3-ECD-E176K-EGFP). Representative traces of
whole-cell sodium currents (INa) in response to an activation
protocol are shown in Fig. 3A. None of the 3-subunit variants
resulted in significant changes in peak INa, voltage, V1⁄2 of maximal
activation or slope factor, and k (p0.05; Fig. 3, B–D, and Table 1).
Typical inactivation traces are shown in Fig. 4, and the
parameters are summarized in Table 1. Expression of WT-3-
EGFP resulted in a 7-mV depolarizing shift of Nav1.5 steady-
state inactivation, agreeing with previous findings (13) express-
ing that 3-E176K-EGFP did not alter this effect. However, the
loss of the extracellular Ig domain completely abolished this
shift, independent of the presence of the Glu-176 residue. The
slope factor, k, exhibited a small but significant decrease in the
presence of WT-3-EGFP, suggesting a slight increase in volt-
age dependence of inactivation.
Both loss of the ECD and the E176K mutation abrogate the
3-mediated acceleration of recovery from Na current
inactivation
It has previously been shown that the 3-subunit accelerates
Na channel recovery from inactivation (13, 23). We sought to
determine whether either the extracellular Ig domain or the
Glu-176 residue influenced this mechanism. Representative
whole-cell Na currents were elicited by a double-pulse proto-
col, whose pulses were separated by progressively incremental
time intervals, t, are shown in Fig. 5. These respective P1 and
P2 pulses yielded peak currents IP1 and IP2. The degrees of
recovery following different time intervals, t, were compared
by obtaining the ratio of IP2/IP1. Plots of IP2/IP1 as a function of
time are fitted to a double exponential, comprising a fast and
slow component, as described under “Experimental proce-
dures.” Both the fast and slow components of Nav1.5 recovery
were accelerated by the co-expression of WT-3-EGFP com-
pared with those obtained with the co-expression of Nav1.5
with EGFP alone (p  0.005; Fig. 5 and Table 2). The 3-E176K
mutation significantly attenuated both of these effects but did
not completely abolish it. The loss of the extracellular Ig
domain also resulted in a slowing of recovery from inactivation
compared with WT-3-EGFP. That was more pronounced in
the fast component. Hence, the kinetic and steady-state data
together indicate overlapping but distinct roles for the Glu-176
residue and the extracellular Ig domain of 3 in regulating
recovery from inactivation.
Distinct roles for the Glu-176 residue and the ECD in
modulating DIII and DIV VSD movement
The Nav channel VSDs are comprised of the first four trans-
membrane -helices (S1–S4) within each of the four internally
homologous Nav channel domains (DI–DIV) (Fig. S1).
Changes in membrane potential initiate movement of the
charged S4 helix within each VSD. This enables channel open-
ing (for the case of DI–DIII VSDs) and subsequent channel
inactivation (for the case of DIV VSD) (1). The regulatory effect
of the 3-subunit on recovery from inactivation arises at least in
part by its modulation of the voltage responses of the DIII and
DIV VSDs (13, 14). Further investigations into the effect of the
Glu-176 residue upon these two VDSs utilized VCF in cut-open
Figure 1. Sequence analysis of 3-structures. A, secondary structure prediction of the 3-subunit transmembrane region and its sequence alignment among a
wide range of vertebrate species. Residue numbers refer to the human sequence. The predicted transmembrane region is colored orange, and the Glu-176 residue is
highlighted. Residues fully conserved between species are indicated with asterisks. B, space-filling model of the 3-subunit with the fully conserved residues of the
transmembrane region shown in magenta. Note that the helix face containing the Glu-176 residue is fully conserved. Analysis and modeling were as described under
“Experimental procedures.” C, cartoon summary of the WT and mutant 3-subunit constructs used in this work and referred to in the text.
Figure 2. 3 homooligomerization and Nav1.5–3 interaction. A, West-
ern blots (WB) of cell lysates singly transfected with WT-3-EGFP or mutant
subunits, cross-linked with BS3. The monomeric full-length -subunits
tagged with EGFP were run at 58 –75 kDa. The multiple bands are indicative
of variations in glycosylation patterns. With BS3, dimeric and trimeric forms
appear at 120 –130 and 180 –200 kDa, respectively. B, co-IP of cell lysates
co-transfected with Nav1.5 HA- and EGFP-tagged 3-subunits or control
EGFP alone. The samples were immunoprecipitated (IP) with a monoclonal
anti-HA. (Nav1.5) antibody coupled to protein G–agarose beads. The bound
and flow-through (supernatant) fractions were separated on SDS-PAGE and
blotted for HA and EGFP. 3-EGFP with and without the ECD and E176K muta-
tion were pulled down with the Nav1.5 HA. The EGFP is only present in the
unbound, flow-through fraction.
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oocytes. Two separate constructs (M1296C and S1618C) were
generated in the Nav1.5 -subunit by site-directed mutagene-
sis. The M1296C introduced a cysteine into the extracellular
loop connecting helices S3 and S4 of the DIII VSD; the S1618C
mutation introduced a cysteine into the extracellular loop con-
necting helices S3 and S4 of the DIV VSD (13, 24) (Fig. S1).
These cysteines were selectively labeled with the fluorophore
MTS-TAMRA. Changes in fluorescence intensity (F) of the
TAMRA adjunct were used to track conformation changes of
the S4 helix in the DIII and DIV VSDs in response to changes in
membrane potential (13). Previous experiments established
that cysteine introduction and labeling of the M1296C and
Figure 3. Nav1.5 steady-state activation properties with and without WT or mutant 3. A, representative whole-cell sodium current recordings from
HEK293F-Nav1.5 cells transfected with WT and mutant 3-subunits in response to a steady-state activation protocol (inset ). B, I/V Boltzmann curves (described
under “Experimental procedures”) of Nav1.5 currents normalized to cell capacitance. C, histograms showing the Nav1.5 peak current densities (INa) with and
without WT and mutant 3-subunits. D, channel conductance as a function of voltage. Curves are fit to a Boltzmann function; V1⁄2 and k were both unaffected
by the presence of the 3-subunit or any of the mutants. For B–D, the data are means  S.D. (n  6; see Table 1 for individual groups), and statistical significance
was tested with one-way ANOVA. All parameters (peak INa, V1⁄2, and k) showed no statistically significant variation (p  0.2). See Table 1 for individual values.
Table 1
Nav1.5 activation and steady-state inactivation and recovery from inactivation parameters with and without the 3 WT and mutant subunits
Activation (G/Gmax) and inactivation data are fit to the Boltzmann function, and V1⁄2 and k were derived from this. Peak INa is the mean of the absolute maximum INa elicited
by each cell during the activation protocol. All data are means  S.D. (n  6, indicated in the table), compared using one-way ANOVA (p  0.2 for all activation parameters,
and p  0.01 for inactivation parameters). Parameters that were determined to be statistically significant were subjected to a Sidak’s multiple comparison post hoc test (all
conditions were compared against Nav1.5  EGFP and Nav1.5  3-EGFP).
Activation (G/Gmax) Inactivation
HEK293F cells Peak INa V1⁄2 k n V1⁄2 k n
mV mV mV mV
Nav1.5  EGFP 295.6  134.2 41.42  6.29 7.31  1.92 6 82.21  4.81a 8.07  0.86b 10
Nav1.5  FL 3-EGFP 327.0  140.6 38.63  5.49 8.03  1.93 8 75.2  4.00 6.91  0.75 13
Nav1.5  FL 3-E176K-EGFP 328.0  223.9 40.29  4.55 8.2  0.79 9 76.28  2.22c 7.33  0.67 10
Nav1.5  ECD-3-EGFP 272.6  141.2 40.14  6.48 9.09  2.06 12 80.06  5.28b 7.99  0.90b 13
Nav1.5  ECD-3-E176K-EGFP 278.1  81.85 38.01  7.12 9.41  2.59 13 81.36  4.64a 7.79  0.92 13
a p  0.01 compared with Nav1.5  3.
b p  0.05 compared with Nav1.5  3.
c p  0.01 compared with Nav1.5.
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S1618C Nav1.5 constructs caused only small changes in chan-
nel gating properties compared with WT Nav1.5 (24). More-
over, co-expression of the 3-subunit with MTS-TAMRA
labeled M1296C and S1618C Nav1.5 constructs caused similar
gating shifts as with the WT Nav1.5 channel (13). On this basis,
we conclude that the interactions between Nav1.5 -subunit
and the 3-subunit are not fundamentally compromised by the
VCF mutations or the MTS-TAMRA labeling.
For the DIII VSD, the presence of the full-length, WT
3-subunit (WT-3-EGFP) resulted in the activation of DIII
VSD occurring at less negative potentials but at a similar rate.
This produced a significantly depolarized V1⁄2 of the S4 helix
movement, compared with Nav1.5 alone. This effect was abro-
gated by expression of the 3-E176K-EGFP, which activated
the DIII VSD at similar potentials to Nav1.5 expressed alone,
but at a slower rate. This suggests the Glu-176 residue is impor-
Figure 4. Effects of the 3-subunit on Nav1.5 steady-state inactivation are mediated through the ECD. A, representative whole-cell Na currents in
response to a steady-state inactivation protocol (inset). B, peak INa from each sweep normalized to the maximum peak INa (INa/INa.max) of all sweeps and plotted
as a function of the pre-pulse voltage step. The data are means  S.D. (n  10, see Table 1 for individual values) and are separated by Nav1.5  EGFP,
WT-3-EGFP, and 3-E176K-EGFP in the left panel and Nav1.5  EGFP, ECD-3-EGFP, and ECD-3-E176K-EGFP in the right panel. The Nav1.5  EGFP is the
same in both graphs; the separation is for clarity. The curves are fit to Boltzmann functions (see “Experimental procedures”). The statistical significance of the
V1⁄2 and k values produced were determined using one-way ANOVA (both V1⁄2 and k; p  0.01) followed by a Sidak’s multiple comparison post hoc test (all
conditions were compared against Nav1.5  EGFP and Nav1.5  3-EGFP). V1⁄2 of Nav1.5 steady-state inactivation is positively shifted by the full-length 3 and
the 3 with the single transmembrane E176K point mutation (Nav1.5  EGFP versus WT-3, p 	 0.0026; and Nav1.5  EGFP versus 3-E176K-EGFP, p 	 0.0263).
Removal of the Ig-like ECD abolishes these shifts (Nav1.5  EGFP versus 3-ECD-EGFP, p 	 0.865; and Nav1.5  EGFP versus 3-ECD-E176K-EGFP, p 	 0.99).
See Table 1 for all comparisons.
Figure 5. Acceleration of Nav1.5 recovery from inactivation by 3 is abolished with loss of the ECD or the transmembrane glutamic acid. Recovery
from inactivation is expressed as the fraction of current produced by a second pulse over time following an identical pre-pulse (see “Experimental procedures”).
The data are means  S.D. (n  7, see Table 2) fit to double exponential functions, and the parameters (k, , and t1⁄2 for both the fast and slow components) are
compared with one-way ANOVA (p  0.002 for all) followed by a Sidak’s multiple comparison post hoc test (all conditions were compared against Nav1.5 
EGFP and Nav1.5  3-EGFP). Nav1.5  EGFP, WT-3-EGFP, and 3-E176K-EGFP are in the left panel, and Nav1.5  EGFP, ECD-3-EGFP, and 3-ECD-E176K-
EGFP are in the right panel. The Nav1.5  EGFP is the same in both graphs; the separation is for clarity. Nav1.5 recovery from inactivation was accelerated by the
presence of the WT full-length 3-subunit (Nav1.5  EGFP versus WT-3-EGFP, p  0.001 for all fast and slow components). This effect was lost with the
full-length 3-E176K mutation (Nav1.5  EGFP versus 3-E176K-EGFP, p  0.05) and loss of the ECD (Nav1.5  EGFP versus 3-ECD). See Table 2 for full details.
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tant in mediating the effect of the 3-subunit on DIII VSD
modulation. In contrast, the 3-ECD-EGFP mutant and the
3-ECD-E176K-EGFP double mutant activated the DIII VSD
at more hyperpolarized potentials; this was such a drastic effect
that it produced a significantly hyperpolarized shift of V1⁄2 even
compared with Nav1.5 expressed in the absence of the 3-sub-
unit. However, there does not appear to be an additive effect in
the double mutation (Fig. 6 and Table 3). The slope factor (k),
which is inversely proportional to charge movement across
the membrane (see “Discussion”), was almost doubled by the
3-E176K-EGFP mutant, yet the 3-ECD-EGFP and the
3-ECD-E176K-EGFP mutants, as well as the WT-3-EGFP
subunit, had little effect on this parameter compared with
Nav1.5 expressed alone (Fig. 6 and Table 3).
For the case of the DIV VSD, the WT-3-EGFP and mutants
had little effect on V1⁄2 for the S4 helix movement relative to
Nav1.5 -subunit alone. However, WT-3-EGFP caused the
initial activation of the DIV-VSD to occur at a more positive
potential than in the absence of 3 and showed a greater voltage
dependence of activation, with a reduced slope factor for the S4
helix movement in DIV VSD. These effects of 3 were not
altered by the presence of the E176K mutation. The 3-ECD-
EGFP single mutation activated the DIV-VSD at more negative
potentials compared with WT-3-EGFP. In addition, there was
a significantly decreased voltage dependence of activation with
increased slope k values compared with WT-3-EGFP and
E176K-EGFP, whereas the 3-ECD-E176K-EGFP double
mutant produced a still greater increase in k (Fig. 6 and Table 3).
Taken together, these results suggest that the 3-subunit Glu-
176 residue and the ECD both influence movement of the DIII
VSD, albeit through distinct mechanisms. In addition, the ECD is
also important in mediating the effects of the 3-subunit on the
voltage dependence of the DIV VSD movement (Fig. 6 and Table
3), translating to the depolarizing shift of V1⁄2 inactivation exhibited
with co-expression of full-length WT 3-subunit.
Discussion
Previous work has shown that distinct structural regions and
domains within the 3-subunit modify discrete aspects of Nav
channel gating behavior (10, 15, 25). Here, we explore the func-
tional significance of additional structural features within the
3-subunit protein: in particular, the Glu-176 residue within
the transmembrane -helix.
Glutamic acid is significantly under-represented within
-helical transmembrane sequences. This relative rarity
probably reflects the thermodynamic cost of burying a
potentially negatively charged side chain in a hydrophobic
environment (18). In principle, such an unfavorable interac-
tion could be compensated by allowing water molecules to
surround the side chain or by an increase in the pKa of the
glutamic acid side chain so that it remains largely protonated
and uncharged when inside the membrane. However, both
possibilities could have important structural consequences
(17). Given these constraints, the striking evolutionary con-
servation of the Glu-176 residue strongly argues for its func-
tional significance. Interestingly, the pattern of maximum
sequence conservation throughout the entire transmembrane
-helix shows an approximate 4:3 periodicity. This will generate a
helix where the maximally conserved residues, including Glu-176,
all lie on the same face (Fig. 1, B and C). We therefore suggest that
the Glu-176 residue is part of a larger feature, most likely a binding
or interaction site.
The Nav channel -subunits are members of the immuno-
globulin superfamily and are related to members of the cell-
adhesion N-CAM family. Indeed, Nav -subunits can function
as cell-adhesion molecules independently of the Nav -sub-
units (26). Nav -subunits can also adopt multiple oligomeric
states in the absence of Nav -subunits. For example, the 2
and 4-subunits can assemble as both cis and trans oligomers
to promote trans cell adhesion (27). Similarly, the full-length
3-subunit can form cis-interacting dimers and trimers when
expressed in cells without the Nav -subunit (21). We have
previously suggested that the membrane-embedded, proto-
nated form of the Glu-176 residue could help stabilize these
3-subunit dimer and trimers by intersubunit hydrogen bond-
ing (16, 21). However, our new data indicate that oligomeriza-
tion of the full-length 3-subunit does not depend on the pres-
ence of the Glu-176 residue but depends on the presence of an
intact ECD (Fig. 2A). This is consistent with structural data
showing the purified ECD immunoglobulin domain can form
trimers in vitro (21) and implies that the Glu-176 residue has
been conserved for other purposes.
The location of the physiologically relevant 3-binding site on
the Nav1.5 -subunit is currently uncertain. Recent cryo-EM
structures for the eel Nav channel, human Nav1.4, and human
Table 2
Nav1.5 recovery from inactivation parameters with and without the 3 WT and mutant subunits
Recovery from inactivation data is fit to a double exponential function. All data are means  S.D. (n  7, indicated in the table). Statistically significant results were
determined using one-way ANOVA (all parameters p  0.0006) and compared with a Sidak’s multiple comparison post hoc test (all conditions were compared against
Nav1.5  EGFP and Nav1.5  3-EGFP).
Recovery from inactivation
HEK293F cells kfast kslow fast slow t1⁄2 fast t1⁄2 slow n
ms ms ms ms
Nav1.5  EGFP 0.175  0.025a 0.028  0.015a 5.83  0.848a 49.14  31.506b 4.041  0.588a 34.06  21.837a 12
Nav1.5  FL 3-EGFP 0.429  0.181 0.134  0.081 2.807  1.32 12.04  11.011 1.942  0.910 8.34  7.632 9
Nav1.5  FL 3-E176K-EGFP 0.222  0.064b 0.039  0.028b 4.81  1.262 40.12  27.38 3.335  0.875 27.81  18.976 7
Nav1.5  ECD-3-EGFP 0.203  0.063a 0.059  0.033b 5.442  2.011b 22.23  11.917c 3.772  1.394b 15.41  8.26c 10
Nav1.5  ECD-3-E176K-EGFP 0.226  0.112a 0.07  0.054d 5.182  1.870b 23.69  15.821 3.592  1.296b 16.42  10.966 10
a p  0.001 compared with Nav1.5  3.
b p  0.01 compared with Nav1.5  3.
c p  0.05 compared with Nav1.5.
d p  0.05 compared with Nav1.5  3.
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Nav1.7 have identified the binding site for the 1-subunit trans-
membrane region between the S1 and S2 helices of the DIII VSD
(11, 28, 29). The transmembrane regions of the 1 and the 3-sub-
units share significant sequence similarity, and this includes a glu-
tamic acid in the 1 sequence at the equivalent position to Glu-176
in 3 (9). It is therefore tempting to assume that the 1 and 3
transmembrane regions may bind to the same site, and previous
VCF experiments do indeed indicate that the 3-subunit trans-
membrane region binds within the DIII VSD (13). However, sev-
eral independent lines of evidence suggest that this hypothesis may
be too simplistic. For example, in contrast to the results presented
here, the equivalent Glu to Lys mutation in the transmembrane
region 1 induced a significant shift in V1⁄2 for steady-state inacti-
vation but had no effect on the recovery from inactivation (30).
Then VCF experiments showed that unlike 3, the 1-subunit did
not affect V1⁄2 or k for fluorescence changes in DIII for Nav1.5 (13).
Furthermore, an introduced tryptophan in the 3-ECD neck con-
necting the Ig domain to the transmembrane region was able to
quench the fluorescence signal from MTS-TAMRA selectively
tagged at position 1296 of Nav1.5. This places the 3 neck region
no more than 15 Å from residue 1296 of the Nav1.5 DIII, S3–S4
extracellular loop (13), a distance that is too short to be compatible
with the known location of the 1-subunit transmembrane region
on DIII between S1 and S2 (11, 12). Crucially, the same fluores-
cence quenching experiments, using an equivalent tryptophan
mutation on the 1-subunit failed to detect quenching from
Figure 6. Effects of the 3-subunits on Nav1.5 VSD movements as detected by VCF. A, voltage dependence of fluorescence changes in DIII and DIV of Nav1.5. All
curves are fit with a Boltzmann function, and the corresponding data points are means  S.D. (n  3, see Table 3) compared by one-way ANOVA (all parameters p 
0.0005) and followed by a Sidak’s multiple comparison post hoc test (all conditions were compared against Nav1.5  EGFP and Nav1.5  3-EGFP; see Table 3 for full
results). Upper left panel, normalized change in DIII fluorescence plotted (means  S.D.) as a function of test potential (F–V curve) for Nav1.5  alone and with WT-3 or
3-E176K. WT-3 induces a depolarizing shift in the F–V curve compared with Nav1.5 alone (Nav1.5 versus Nav1.53-EGFP; p	0.0002), an effect lost in the presence
of the E176K mutation (Nav1.5  3-EGFP versus Nav1.5  3-E176K-EGFP; p  0.0001). Adjacent insets show corresponding representative fluorescence signals and
test protocol. Upper right panel, DIV F–V curve for  alone and with WT-3 or 3-E176K. The presence of either WT-3 or 3-E176K induces a depolarizing rightward
shift in the initial activation of DIV, but the movement is accelerated compared with Nav1.5 alone. Adjacent insets show corresponding representative VCF traces and
test protocol. Lower left panel, DIII F–V curve for  alone or with 3-ECD or 3-ECD-E176K. The loss of the ECD results in a hyperpolarizing leftward shift (Nav1.5 
3-EGFP versus Nav1.5  3-ECD, p  0.0001; and Nav1.5  3-EGFP versus Nav1.5  3-ECD-E176K-EGFP, p  0.0001). Adjacent insets show the corresponding
representative fluorescence signals, where the movement of the DIII sensor is noticeably attenuated by the presence of either3-subunits lacking the ECD. Lower right
panel, DIV F–V curve foralone or with3-ECD or3-ECD-E176K.3-ECD and3-ECD-E176K co-expression result in differing degrees of rightward depolarizing
shift of the curve. Adjacent insets show the corresponding representative fluorescence signals, where the movement of the DIV sensor like the DIII sensor is noticeably
attenuated. B, histograms of the mean ( S.D., n  3) V1⁄2 (left panel) and k (right panel) values for DIII and DIV from the Boltzmann curve fits of the data in A. Table 3 has
the full numerical values and statistical comparisons.
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Nav1.5 tagged with MTS-TAMRA at position 1296 (13). On this
basis, we propose that the 3 transmembrane -helix is more
likely to lie between the Nav1.5 DIII S3 and S4 helices. This could
allow the 3 ECD to interact with the DI-S5 and DIV-S5 extracel-
lular loops but in a different orientation compared with 1 ECD.
As a result, the full-length 3-subunit could potentially influence
both DIII and DIV in a way that is distinct from 1.
As judged by immunoprecipitation, the 3-E176K-EGFP
mutation interacted with the Nav1.5 -subunit, although the
amount of E176K 3 co-precipitated with Nav1.5 was some-
what reduced compared with WT 3 (Fig. 2B). This could
reflect a somewhat lower affinity of the E176K 3 mutant for
the Nav1.5 -subunit, leading to lower retention of the E176K
3 mutant during the immunoprecipitation and extensive
washing steps. However, both the E176K mutant and the WT
3-subunits induced a similar depolarizing shift in the V1⁄2 of
Nav channel inactivation relative to that shown by the Nav1.5
-subunit alone (Fig. 4 and Table 1). Therefore, the E176K
mutant was still capable of functionally interacting with the
Nav1.5 -subunit in vivo.
To investigate the roles of the 3-subunit Glu-176 residue
and its ECD, we used both patch-clamp electrophysiology and
VCF. These two approaches provide complementary but differ-
ent insights into Nav channel behavior. The electrophysiology
reflects a culmination of all the steps and conformational
changes that must occur before the channel can activate or
inactivate. On the other hand, VCF experiments provide a more
specific insight into voltage-dependent movements that occur
in the S4 helices of individual VSDs, which subsequently lead to
activation and/or inactivation (31).
The VCF experiments showed that in the absence of the
3-subunit, the V1⁄2 for the movement of the DIII S4 helix was
nearly 50 mV more hyperpolarized than the equivalent value
for the DIV S4 helix. Hence, for Nav1.5 alone, a depolarizing
signal will initiate S4 helix movement considerably sooner in
DIII than in DIV, and there will necessarily be a delay between
the initiation of activation and subsequent inactivation path-
ways. Strikingly, however, the presence of full-length 3-sub-
unit considerably reduced the difference between the V1⁄2 values
for the DIII and DIV S4 helix movements (Fig. 6B and Table 3).
By reducing this difference, the 3-subunit ensured that the
DIII and DIV S4 helix movements occurred over a narrower
voltage range and thus generated a more coordinated depolar-
ization response from these two VSDs. Almost all the 3-in-
duced relative changes in the V1⁄2 values occurred with the
TAMRA-tagged C1296 Nav1.5 construct, suggesting that the
DIII VSD is likely to interact directly with the 3-subunit.
It is striking that, compared with the WT-3-EGFP, the full-
length E176K mutant abrogated the effect of 3 on the voltage
sensitivity of fluorescence changes for DIII VSD, while signifi-
cantly increasing the slope factor k (Fig. 6B and Table 3). The
slope factor, k, is inversely related to the amount of charge that
can move across the membrane during a transition (32). Hence,
the E176K mutant dramatically reduced this value, suggesting
that without the 3-Glu-176 residue, the movement of the S4
helix in DIII during depolarization was compromised or at least
altered relative to WT 3. A role for the Glu-176 residue in
facilitating DIII S4 helix movement could also explain the effect
of the 3-E176K-EGFP mutant on recovery from inactivation
(Fig. 5 and Table 2). The DIII VSD is known to mediate recovery
from inactivation via its interaction with the DIII-DIV linker
region (14). By correctly positioning the DIII S4 helix in the
inactivated state, the Glu-176 residue could in effect catalyze
the 3-dependent accelerated recovery from inactivation as the
membrane potential is repolarized.
Removal of the 3-subunit ECD (both with and without the
E176K mutant) fully abrogated the effects of WT 3-subunit on
the V1⁄2 for voltage-dependent fluorescence changes in DIII
VSD (Fig. 6, A and B, and Table 3). This suggests that the ECD
may play a role in correctly positioning the 3-subunit trans-
membrane -helix. Interestingly, the co-immunoprecipitation
experiments indicated that 3 constructs lacking the ECD bound
to Nav1.5 more intensely compared with WT-3-EGFP (Fig. 2B).
It is therefore possible that the ECD may restrict the binding of the
3-subunit to one or a small number of physiologically appropri-
ate sites on the Nav1.5 -subunit. This could be achieved through
the ECD Ig region interacting with specific extracellular loop
regions on the -subunit. Removal of the ECD could compromise
this discrimination and enable the hydrophobic transmembrane
region more freedom to bind additional sites on the -subunit or
to the same DIII region but with multiple orientations or confor-
mational states, so that the Glu-176 residue is incorrectly posi-
tioned. In this case, the DIII S4 helix movement would no longer be
so sensitive to the presence of the Glu-176 residue.
The DIV VSD plays an important role in steady-state inacti-
vation (33). The WT-3-EGFP subunit reduced the value of k
Table 3
VCF data for DIII and DIV in Nav1.5 with and without the 3 WT and mutant subunits
The V1⁄2 and k values for DIII and DIV are derived from the Boltzmann fit of the normalized change in fluorescence as a function of voltage. All data are means  S.D. (n 
3 indicated in the table). Statistically significant results were determined using one-way ANOVA (all parameters p  0.0005) followed by Sidak’s multiple comparison post
hoc test (all conditions were compared against Nav1.5  EGFP and Nav1.5  3-EGFP).
DIII F-V DIV F-V
Cut-open oocytes V1⁄2 k n V1⁄2 k n
mV mV mV mV
Nav1.5 120.68  9.57a 25.6  1.32 4 72.77  7.79 21.43  5.87 4
Nav1.5  FL 3-EGFP 60.04  5.68 22.26  3.14 3 64.87  7.04 14.38  0.65 3
Nav1.5  FL 3-E176K-EGFP 152.7  19.71a,b 47.59  5.47a,c 3 62.66  4.32 12.93  3.08 5
Nav1.5  ECD-3-EGFP 154.4  6.51a,b 19.75  3.68 3 44.34  2.17c,d 25.67  0.96 3
Nav1.5  ECD-3-E176K-EGFP 164.8  11.67a,e 16.31  1.81b 3 63.68  6.65 34.84  7.51a,e 4
a p  0.01 compared with Nav1.5  3.
b p  0.05 compared with Nav1.5.
c p  0.001 compared with Nav1.5.
d p  0.01 compared with Nav1.5  3.
e p  0.01 compared with Nav1.5.
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for voltage-dependent S4 helix movements in DIV VSD (Fig. 6,
A and B, and Table 3). This change was abolished for 3-sub-
units lacking the ECD (with or without the E176K mutation).
Removal of the ECD also abolished the 3-induced depolariz-
ing shift in steady-state inactivation gating (Fig. 4 and Table 1).
Hence, the 3-ECD is likely to influence DIV, despite its loca-
tion on the DIII VSD. One possibility is that the 3 ECD does
this indirectly by modifying the conformation of the DI S5-S6
extracellular loop, adjacent to the DIV VSD. Alternatively, if the
3 transmembrane region binds to DIII VSD, it is likely that the
ECD will interact with the DIV S5-S6 extracellular loop (Fig.
S1), which could provide a more direct coupling between ECD
and DIV. Furthermore, the magnitude of voltage-dependent
fluorescence changes in DIII and DIV VSDs recorded with both
3-ECD-EGFP and 3-ECD-E176K-EGFP were less pro-
nounced compared with Nav1.5 alone or with full-length 3
constructs (Fig. 6A). Because the fluorescence signal is very sen-
sitive to changes in the immediate environment of the fluoro-
phore (34), it is possible that removal of the ECD subtly altered
the trajectory of the DIII and DIV S4 helix movements com-
pared with Nav1.5 alone or the full-length 3 constructs.
In summary, our data provide new and quantitative insights
into the unique role of the 3-subunit in the regulation of
Nav1.5 gating. In this study, our emphasis has been to clarify the
importance of distinctive and unusually positioned residues
using the simplest and most tractable Nav1.5 - and 3-sub-
units alone. In the future, building on this current work, it will
be interesting to investigate these mutations in a more complex
physiological system such as a cardiomyocyte, using, for exam-
ple, targeted gene replacement methods.
Experimental procedures
Secondary structure predictions and modeling
Secondary structure prediction of the 3-subunit transmem-
brane region was carried out using Phyre2 (35). The alignment
analysis of the 3 transmembrane region among different species
was carried out using Clustal Omega program (36). A structural
model of the 3-subunit was generated using the I-TASSER server
(37).
cDNA constructs, cell culture, mutagenesis, and cell
transfections
Plasmids pcDNA3-Nav1.5-hemagglutinin (HA), pcDNA3
WT-3-EGFP, and pcDNA3 3-ECD-EGFP have been previ-
ously described (10, 15, 38). Site-directed mutagenesis of
WT-3-EGFP and 3-ECD-EGFP to introduce the E176K
mutation was performed using the QuikChange Lightning kit
(Agilent) with primers (designed complementary to the 3
sequence, except for the appropriate base change for glutamic
acid to lysine (E176K) in the middle of the primer) from Sigma.
Colonies were picked and grown in culture medium overnight,
plasmids were then extracted using the Genelute plasmid mid-
iprep kit (Sigma), and successful mutation was identified by
Sanger sequencing (DNA sequencing facility, University of
Cambridge). Separate Nav1.5 constructs containing the M1296C
and S1618C were generated as previously described (24).
Human embryonic kidney (HEK293F) cells and HEK293F
cells stably expressing Nav1.5 (HEK293F-Nav1.5) were main-
tained in Dulbecco’s modified Eagle’s medium (Dulbecco’s
modified Eagle’s medium/F-12 GlutaMAX; Invitrogen) with
10% fetal bovine serum (Sigma–Aldrich) at 37 °C and 5% CO2.
Transient transfections were performed using polyethyleni-
mine (1 g/l) at a polyethylenimine/DNA ratio of 3:1. For
whole-cell patch-clamp electrophysiology, HEK293F-Nav1.5
cells were plated on 18-mm coverslips in 6-well plates and tran-
siently transfected with either 1 g of the empty vector
pEGFP-N1 or appropriate 3 plasmid DNA. For co-immuno-
precipitation studies, HEK293F cells were co-transfected with 3
g of Nav1.5 HA and 3 g of either pEGFP-N1 or appropriate
3-GFP. For 3 cross-linking experiments, 8 g of appropriate
WT or mutant 3-GFP constructs were transfected.
Co-immunoprecipitation
48 h post-transfection, the cells were washed three times in
cold PBS and then lysed in 1 ml of lysis buffer (50 mM Tris, 150
mM NaCl, 1% Triton X-100 (v/v)) supplemented with protease
inhibitor mixture (Roche, Sigma–Aldrich)). Lysates were vor-
texed, stored on ice for 30 min, and centrifuged at 10,000 
 g for
10 min at 4 °C, and the pellet (cell debris) fraction was dis-
carded. Lysates were incubated in either mouse anti-GFP tag or
mouse anti-HA with end-over-end rotation at 4 °C overnight,
followed by the addition of protein G–agarose for 4 h. The
samples were spun at 2,000 
 g at 4 °C for 5 min. Pellet (bound)
fractions were washed four times in 1 ml of lysis buffer, and
both these and the supernatants (unbound) were incubated in
4
 NuPage loading buffer supplemented DTT at 85 °C for 10
min. The bound and unbound fractions were separated on
SDS-PAGE and transferred to nitrocellulose membranes, and
Western blotting was carried out with rabbit polyclonal anti-
bodies anti-GFP (GeneTex, Insight Biotech) and anti-HA
(Santa Cruz, Insight Biotech) to detect EGFP as well as the
3-GFP WT and mutants and Nav1.5-HA, respectively.
BS3 cross-linking experiments
Transfected cells were washed three times in Hanks’ bal-
anced salt solution and then lysed in Hanks’ balanced salt solu-
tion lysis buffer (1% Triton X-100, 0.2% SDS, 0.5% sodium
deoxycholate) supplemented with protease inhibitors (Roche
cOmplete Protease Inhibitor mixture). Each lysate was sepa-
rated into two equal fractions, one of which was incubated with
BS3 (5 mM) for 1 h at 4 °C. The reaction was quenched with
glycine (74 mM), and the lysate was clarified at 10,000 
 g for 10
min at 4 °C. The lysates were then subjected to SDS-PAGE and
transferred to nitrocellulose membranes, and Western blotting
was carried out with rabbit polyclonal antibodies anti-GFP
(GeneTex, Insight Biotech) and anti-myc (Santa Cruz, Insight
Biotech) to detect 3-GFP and 3-myc, respectively.
Whole-cell patch clamp
Na currents (INa) were recorded from HEK293F cells stably
expressing Nav1.5 and transiently transfected with 1 g of the
3 constructs or a vector containing only EGFP. Successfully
transfected cells were identified by EGFP fluorescence on an
Olympus IX71 inverted microscope. Experiments were carried
out at room temperature (22–23 °C) in the whole-cell configu-
ration with an Axopatch 200B amplifier (Axon Instruments), a
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Digidata 1322A digitizer (Axon Instruments), and the Strath-
clyde Electrophysiology Software Package (WinWCP, Depart-
ment of Physiology and Pharmacology, University of Strath-
clyde). The extracellular bath solution contained 60 mM NaCl, 2
mM KCl, 1.5 mM CaCl2, 10 mM glucose, 1 mM MgCl2, 90 mM
CsCl2, 10 mM HEPES, pH 7.39  0.02 with NaOH. 1.5–2.5 M
patch pipettes were produced from borosilicate glass capillaries
(Harvard Apparatus Ltd.) using a horizontal puller (P-87; Sutter
Instruments) and filled with intracellular saline comprised of 35
mM NaCl, 105 mM CsF, 10 mM EGTA, 10 mM HEPES, pH 7.39 
0.02 with CsOH. Signals were low-pass Bessel filtered at a fre-
quency of 5 kHz and sampled at 125 kHz. Series resistance
compensation was performed to 75– 80%, and leak currents
were subtracted using a P/4 protocol. The liquid junction potential
(2 mV) was not corrected for. Data from cells with a current ampli-
tude larger than 8 nA or with a clear loss of voltage control as
demonstrated by poor I/V relationships were removed.
Voltage protocols
All voltage protocols used a holding voltage of 120 mV. The
steady-state inactivation and activation protocol consisted of a
100-ms depolarizing pulse ranging from 140 mV to 35 mV,
in 5-mV increments, followed by a fixed 40 mV depolarizing
pulse of 50-ms duration. Currents elicited from the first pulse
constitute activation data and those from the second depolar-
izing pulse provide inactivation data.
Current traces were normalized against the whole-cell
capacitance (Cm), and the I/V relationship was plotted from the
peak current at each test voltage. The values of Na conduct-
ance (GNa), for families of traces at each test voltage, were deter-
mined from the equation,
GNa  INa/V 	 ENa) (Eq. 1)
where INa is the Na current and ENa is the Na reversal poten-
tial. Peak GNa was plotted as a function of voltage to produce
activation curves. INa was normalized to the maximum elicited
current and plotted against the conditioning voltage to yield
inactivation curves. Both curves were fitted to the following
Boltzmann function,
G/Gmax  1/1 
 expV 	 V1⁄2/k (Eq. 2)
where G/Gmax is the normalized conductance or current, V1⁄2 is
the voltage of half-maximal activation or inactivation, k is the
slope factor, and V is the test voltage or conditioning voltage.
Recovery from inactivation was examined using a double-pulse
P1 and P2 protocol that delivered two identical depolarizing pulses
to 40 mV of 50-ms duration. The time interval between P1 and
P2 was initially incremented by 1 ms up to 6 ms, followed by 2-ms
increments to 20 ms, then 5-ms increments to 60 ms, followed by
10-ms increments to 120 ms, and finally 20-ms increments to 200
ms to ensure enough time was allowed for full recovery and to
allow adequate capture of the fast components. Peak currents
from P2 were normalized to those obtained in response to the
conditioning P1 step and plotted against the time intervals. These
plots were fitted with a double exponential function as follows,
y  	 A1exp 	 t/1) 	 A2exp 	 t/2) (Eq. 3)
where t is the time, and  is the time constant of recovery from
inactivation.
VCF in oocytes
cRNAs for the human NaV 3 (UniProtKB/Swiss-Prot under
accession no. Q9NY72) and -subunit NaV1.5 (accession no.
Q14524.1) were produced from the pBSTA and pMAX vectors,
respectively. All mutagenesis was accomplished using the
QuikChange II site-directed mutagenesis kit (Agilent), with
primers from Sigma–Aldrich. Multiple colonies were picked,
and plasmids were isolated using the NucleoSpin plasmid mini-
prep kit (Macherey–Nagel). After samples were confirmed with
sequencing (Genewiz), a single clone was selected for a Mid-
iprep preparation (NucleoBond Xtra Midi; Macherey–Nagel).
PBSTA and pMAX plasmid were linearized with the NotI and
SpeI restriction enzymes, respectively, and purified with the
NucleoSpin gel and PCR clean-up kit (Macherey–Nagel).
Finally, capped mRNA was synthesized in vitro using the
mMESSAGE mMACHINE t7 transcription Kit (Life Technol-
ogies), purified via phenol-chloroform extraction, and reconsti-
tuted to a concentration of 1 g/l.
The mRNAs for the human -subunit NaV1.5 and 3-sub-
units were injected at a 3:1 molar ratio (50 –56 ng per cell total)
into Xenopus oocytes. The oocytes were then incubated at 18 °C
in ND93 solution (93 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, 5 mM HEPES, 2.5 mM sodium pyruvate, and 1% penicil-
lin-streptomycin, pH 7.4). 5–7 days after injection, VCF record-
ings were performed. Before recording, the oocytes were
labeled with 10 mol/liter MTS-TAMRA (Santa Cruz Biotech-
nology) in a depolarizing solution (110 mM KCl, 1.5 mM MgCl2,
0.8 mM CaCl2, 0.2 mM EDTA, and 10 mM HEPES, pH 7.1) for 30
min on ice. Fluorescence data were collected simultaneously
with ionic current on a custom rig as described previously (13,
24). Each fluorescence trace is a mean of 7–10 fluorescence
recordings of the same cell.
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